Similarly, patients with the SCN2A DN mutation show other comorbid conditions, including ID (3/3) and seizures (2/3) consistent with the observation that SCN2A DN mutations have been identified among ID and epileptic encephalopathy patient cohorts21, 22, 25. This evidence concerns the gene SCN2A and Epileptic encephalopathy.